NCT02666378View on ClinicalTrials.gov

Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

September 10, 2018

Primary Completion Date

July 10, 2024

Study Completion Date

July 10, 2024

Conditions
Breast Cancer
Interventions
OTHER

Cardiac Magnetic Resonance Imaging (CMR)

Subjects will be recruited for observational cardiac magnetic resonance imaging.

OTHER

Echocardiogram (ECHO)

Subjects will undergo a research echocardiogram if a clinical echocardiogram has not already been ordered.

Trial Locations (1)

02115

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

American Heart Association

OTHER

collaborator

Dana-Farber Cancer Institute

OTHER

lead

Beth Israel Deaconess Medical Center

OTHER

NCT02666378 - Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer | Biotech Hunter | Biotech Hunter